{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:14Z","timestamp":1792787834617,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["No. 82203365"],"award-info":[{"award-number":["No. 82203365"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["No. 20232BAB206090"],"award-info":[{"award-number":["No. 20232BAB206090"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16397-1","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:13:05Z","timestamp":1782727985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated multi-omics analysis reveals folate metabolism-related genes as prognostic markers and therapeutic targets in clear cell renal cell carcinoma"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8821-745X","authenticated-orcid":false,"given":"Jinkang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-7625","authenticated-orcid":false,"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6803-9131","authenticated-orcid":false,"given":"Yunxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5972-7576","authenticated-orcid":false,"given":"Zecao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7134-7047","authenticated-orcid":false,"given":"Weilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1248-8960","authenticated-orcid":false,"given":"Huanhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8846-0110","authenticated-orcid":false,"given":"Shun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2005-3478","authenticated-orcid":false,"given":"Jiabiao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9994-0950","authenticated-orcid":false,"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5640-9398","authenticated-orcid":false,"given":"Chen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-7807","authenticated-orcid":false,"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9120-759X","authenticated-orcid":false,"given":"Haibo","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9119-0529","authenticated-orcid":false,"given":"Jin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"3","key":"16397_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16397_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","volume":"75","author":"B Ljungberg","year":"2019","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fern\u00e1ndez-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol. 2019;75(5):799\u2013810.","journal-title":"Eur Urol"},{"issue":"5","key":"16397_CR3","first-page":"529","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, Kassouf W, Mitchell T, Montironi R, O\u2019Brien T, et al. Epidemiol Ren Cell Carcinoma: 2022 Update Eur Urol. 2022;82(5):529\u201342.","journal-title":"Epidemiol Ren Cell Carcinoma: 2022 Update Eur Urol"},{"key":"16397_CR4","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.","journal-title":"Nat Rev Dis Primers"},{"issue":"5112","key":"16397_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317\u201320.","journal-title":"Science"},{"issue":"1","key":"16397_CR6","doi-asserted-by":"publisher","first-page":"e985082","DOI":"10.4161\/2162402X.2014.985082","volume":"4","author":"K Geissler","year":"2015","unstructured":"Geissler K, Fornara P, Lautenschl\u00e4ger C, Holzhausen HJ, Seliger B, Riemann D. Immune signature of tumor infiltrating immune cells in renal cancer. Oncoimmunology. 2015;4(1):e985082.","journal-title":"Oncoimmunology"},{"issue":"1","key":"16397_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.drudis.2021.07.009","volume":"27","author":"O Pontes","year":"2022","unstructured":"Pontes O, Oliveira-Pinto S, Baltazar F, Costa M. Renal cell carcinoma therapy: Current and new drug candidates. Drug Discov Today. 2022;27(1):304\u201314.","journal-title":"Drug Discov Today"},{"issue":"3","key":"16397_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","volume":"56","author":"J Hu","year":"2024","unstructured":"Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, Li N, Zhou L, Yang Y, Wang L, et al. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat Genet. 2024;56(3):442\u201357.","journal-title":"Nat Genet"},{"issue":"1","key":"16397_CR9","doi-asserted-by":"publisher","first-page":"188559","DOI":"10.1016\/j.bbcan.2021.188559","volume":"1876","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Metabolic reprogramming in renal cancer: Events of a metabolic disease. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188559.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"16397_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-022-02583-z","volume":"42","author":"X Chen","year":"2023","unstructured":"Chen X, Yong H, Chen M, Deng C, Wang P, Chu S, Li M, Hou P, Zheng J, Li Z, et al. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability. J Exp Clin Cancer Res. 2023;42(1):34.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"16397_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12943-025-02457-w","volume":"24","author":"Q Deng","year":"2025","unstructured":"Deng Q, Ji Y, Liu J, Wen T. Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting. Mol Cancer. 2025;24(1):236.","journal-title":"Mol Cancer"},{"issue":"3","key":"16397_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s42255-021-00367-x","volume":"3","author":"H Xie","year":"2021","unstructured":"Xie H, Song J, Godfrey J, Riscal R, Skuli N, Nissim I, Simon MC. Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma. Nat Metab. 2021;3(3):327\u201336.","journal-title":"Nat Metab"},{"issue":"10","key":"16397_CR13","doi-asserted-by":"publisher","first-page":"116429","DOI":"10.1016\/j.celrep.2025.116429","volume":"44","author":"H Wang","year":"2025","unstructured":"Wang H, Xiao T, Zhuang H, Liu Y, Jin K, Li J, Li J, Gao Y, Yue D, Cui W, et al. STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinoma. Cell Rep. 2025;44(10):116429.","journal-title":"Cell Rep"},{"key":"16397_CR14","doi-asserted-by":"publisher","first-page":"116247","DOI":"10.1016\/j.bcp.2024.116247","volume":"224","author":"H Liu","year":"2024","unstructured":"Liu H, Wang L, Shi X, Yin L, Zhai W, Gao S, Chen Y, Zhang T. Calcium saccharate\/DUSP6 suppresses renal cell carcinoma glycolytic metabolism and boosts sunitinib efficacy via the ERK-AKT pathway. Biochem Pharmacol. 2024;224:116247.","journal-title":"Biochem Pharmacol"},{"issue":"50","key":"16397_CR15","doi-asserted-by":"publisher","first-page":"eabp8293","DOI":"10.1126\/sciadv.abp8293","volume":"8","author":"AK Kaushik","year":"2022","unstructured":"Kaushik AK, Tarangelo A, Boroughs LK, Ragavan M, Zhang Y, Wu CY, Li X, Ahumada K, Chiang JC, Tcheuyap VT, et al. In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma. Sci Adv. 2022;8(50):eabp8293.","journal-title":"Sci Adv"},{"issue":"23","key":"16397_CR16","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1158\/0008-5472.CAN-23-0969","volume":"83","author":"L Zhou","year":"2023","unstructured":"Zhou L, Luo Y, Liu Y, Zeng Y, Tong J, Li M, Hou Y, Du K, Qi Y, Pan W, et al. Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression. Cancer Res. 2023;83(23):3920\u201339.","journal-title":"Cancer Res"},{"issue":"1","key":"16397_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","volume":"20","author":"SK Tan","year":"2023","unstructured":"Tan SK, Hougen HY, Merchan JR, Gonzalgo ML, Welford SM. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nat Rev Urol. 2023;20(1):48\u201360.","journal-title":"Nat Rev Urol"},{"key":"16397_CR18","doi-asserted-by":"publisher","first-page":"1506967","DOI":"10.3389\/fnut.2024.1506967","volume":"11","author":"J Qin","year":"2024","unstructured":"Qin J, Ouyang C, Zhuang X. Association between folate and glutamine metabolism and prognosis of kidney cancer. Front Nutr. 2024;11:1506967.","journal-title":"Front Nutr"},{"issue":"40","key":"16397_CR19","doi-asserted-by":"publisher","first-page":"27487","DOI":"10.1021\/acsnano.4c08055","volume":"18","author":"M Lv","year":"2024","unstructured":"Lv M, Liu B, Duan Y, Lin J, Dai L, Li Y, Yu J, Liao J, Zhang J, Duan Y. Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and \u03b3-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma. ACS Nano. 2024;18(40):27487\u2013502.","journal-title":"ACS Nano"},{"issue":"8","key":"16397_CR20","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/ijc.23318","volume":"122","author":"LE Moore","year":"2008","unstructured":"Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC, Zaridze D, Janout V, Kollarova H, Bencko V, et al. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer. 2008;122(8):1710\u20135.","journal-title":"Int J Cancer"},{"key":"16397_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040937","author":"CY Huang","year":"2023","unstructured":"Huang CY, Chen WJ, Lee HL, Lin YC, Huang YL, Shiue HS, Pu YS, Hsueh YM. Possible combined effects of plasma folate levels, global DNA methylation, and blood cadmium concentrations on renal cell carcinoma. Nutrients. 2023;15(4). https:\/\/doi.org\/10.3390\/nu15040937.","journal-title":"Nutrients"},{"key":"16397_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020197","author":"Y Menezo","year":"2022","unstructured":"Menezo Y, Elder K, Clement A, Clement P. Folic acid, folinic acid, 5 methyl tetrahydrofolate supplementation for mutations that affect epigenesis through the folate and one-carbon cycles. Biomolecules. 2022;12(2). https:\/\/doi.org\/10.3390\/biom12020197.","journal-title":"Biomolecules"},{"issue":"7","key":"16397_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/01635581.2016.1187283","volume":"68","author":"LJ Schouten","year":"2016","unstructured":"Schouten LJ, Deckers IA, van den Brandt PA, Baldewijns MM, van Engeland M. Alcohol and Dietary Folate Intake and Promoter CpG Island Methylation in Clear-Cell Renal Cell Cancer. Nutr Cancer. 2016;68(7):1097\u2013107.","journal-title":"Nutr Cancer"},{"issue":"7","key":"16397_CR24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ajhg.2021.05.009","volume":"108","author":"J Weile","year":"2021","unstructured":"Weile J, Kishore N, Sun S, Maaieh R, Verby M, Li R, Fotiadou I, Kitaygorodsky J, Wu Y, Holenstein A, et al. Shifting landscapes of human MTHFR missense-variant effects. Am J Hum Genet. 2021;108(7):1283\u2013300.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"16397_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"16397_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"issue":"15","key":"16397_CR27","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/sim.6927","volume":"35","author":"N Tern\u00e8s","year":"2016","unstructured":"Tern\u00e8s N, Rotolo F, Michiels S. Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models. Stat Med. 2016;35(15):2561\u201373.","journal-title":"Stat Med"},{"issue":"5","key":"16397_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"16397_CR29","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"16397_CR30","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, et al. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"issue":"7","key":"16397_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive Integration of Single-Cell Data. Cell. 2019;177(7):1888\u2013e19021821.","journal-title":"Cell"},{"issue":"2","key":"16397_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"12","key":"16397_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"key":"16397_CR34","doi-asserted-by":"publisher","first-page":"1115272","DOI":"10.3389\/fimmu.2023.1115272","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Pei S, Gong Z, Feng Y, Zhang X, Yang F, Wang W. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma. Front Immunol. 2023;14:1115272.","journal-title":"Front Immunol"},{"issue":"1","key":"16397_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-023-01924-6","volume":"23","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Y, Sun Y, Liu Q, Gu Y, Huang Y, Zeng Z, Tang F, Ouyang Y. Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis. Mol Cancer. 2024;23(1):11.","journal-title":"Mol Cancer"},{"issue":"1","key":"16397_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang E, Liu G, Chu X, Liu X, Liu W, et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol. 2024;17(1):80.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"16397_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu CH, Lei M, Zeng Q, Li L, Tang H, Zhang N. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024;9(1):268.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"16397_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919.","journal-title":"Protein Cell"},{"key":"16397_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"EJ Huang","year":"2003","unstructured":"Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609\u201342.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"16397_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017;25(1):27\u201342.","journal-title":"Cell Metab"},{"issue":"1","key":"16397_CR41","doi-asserted-by":"publisher","first-page":"22775","DOI":"10.1038\/s41598-024-73574-7","volume":"14","author":"WN Gao","year":"2024","unstructured":"Gao WN, Chen LG, Bao LR, He N, Hu TL, Lai C, Xu RF, Wang XF, Wang JY, Zhao JR, et al. ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma. Sci Rep. 2024;14(1):22775.","journal-title":"Sci Rep"},{"issue":"30","key":"16397_CR42","doi-asserted-by":"publisher","first-page":"49839","DOI":"10.18632\/oncotarget.17765","volume":"8","author":"B Hong","year":"2017","unstructured":"Hong B, Yang Y, Guo S, Duoerkun S, Deng X, Chen D, Yu S, Qian W, Li Q, Li Q, et al. Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models. Oncotarget. 2017;8(30):49839\u201350.","journal-title":"Oncotarget"},{"issue":"1","key":"16397_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018;23(1):313\u2013e326315.","journal-title":"Cell Rep"},{"key":"16397_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.27.620479","author":"T Pellinen","year":"2025","unstructured":"Pellinen T, Luomala L, Mattila KE, Hemmes A, V\u00e4lim\u00e4ki K, Br\u00fcck O, Paavolainen L, Kankkunen E, Nis\u00e9n H, J\u00e4rvinen P et al. Fibroblast activation protein defines an aggressive, immunosuppressive EMT-associated tumor subtype in highly inflamed localized clear cell renal cell carcinoma. bioRxiv 2025:2024.2010.2027.620479. https:\/\/doi.org\/10.1101\/2024.10.27.620479.","journal-title":"bioRxiv"},{"issue":"9","key":"16397_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.31083\/j.fbl2809196","volume":"28","author":"Y Situ","year":"2023","unstructured":"Situ Y, Zhang J, Liao W, Liang Q, Lu L, Xu Q, Chen J, Lu X, Cui Y, Shao Z, et al. SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma. Front Biosci (Landmark Ed). 2023;28(9):196.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"16397_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.tpj.6500403","volume":"7","author":"S Haenisch","year":"2007","unstructured":"Haenisch S, Zimmermann U, Dazert E, Wruck CJ, Dazert P, Siegmund W, Kroemer HK, Warzok RW, Cascorbi I. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J. 2007;7(1):56\u201365.","journal-title":"Pharmacogenomics J"},{"key":"16397_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063191","author":"WT Lee","year":"2024","unstructured":"Lee WT, Wu PY, Cheng YM, Huang YF. Tissue inhibitor of metalloproteinase 3: unravelling its biological function and significance in oncology. Int J Mol Sci. 2024;25(6). https:\/\/doi.org\/10.3390\/ijms25063191.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16397-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16397-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16397-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:24:22Z","timestamp":1789629862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16397-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16397"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16397-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9129596\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1107"}}